Vericel Competitors

VCEL Stock  USD 36.94  0.96  2.67%   
Vericel Corp Ord competes with Uniqure NV, Structure Therapeutics, Edgewise Therapeutics, Viridian Therapeutics, and Aurinia Pharmaceuticals; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Vericel Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Vericel Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Vericel Corp Correlation with its peers.

Vericel Corp vs Ocular Therapeutix Correlation

Good diversification

The correlation between Vericel Corp Ord and OCUL is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and OCUL in the same portfolio, assuming nothing else is changed.

Moving against Vericel Stock

  0.43WMT Walmart Common Stock Aggressive PushPairCorr
  0.38BA BoeingPairCorr
  0.33CAT CaterpillarPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vericel Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
34.0636.9439.82
Details
Intrinsic
Valuation
LowRealHigh
35.1037.9840.86
Details
Naive
Forecast
LowNextHigh
33.2436.1239.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
34.8037.4740.13
Details

Vericel Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vericel Corp and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Vericel and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vericel Corp Ord does not affect the price movement of the other competitor.

High positive correlations

HRMYMESO
VRDNEWTX
EWTXGPCR
MESOMNKD
VRDNGPCR
HRMYNUVB
  

High negative correlations

VRDNQURE
AUPHQURE
EWTXQURE
GPCRQURE
MNKDAUPH
NUVBQURE

Risk-Adjusted Indicators

There is a big difference between Vericel Stock performing well and Vericel Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vericel Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
QURE  4.61 (1.04) 0.00 (1.03) 0.00 
 9.37 
 49.34 
GPCR  5.09  2.21  0.55 (1.31) 2.99 
 8.96 
 110.34 
EWTX  4.21  1.06  0.23  1.25  4.12 
 14.33 
 38.85 
VRDN  1.92  0.50  0.29  1.31  1.31 
 5.57 
 15.86 
AUPH  1.71  0.33  0.15  0.86  1.78 
 4.75 
 14.95 
NUVB  4.14  0.43  0.08  0.58  4.60 
 7.33 
 68.61 
MNKD  1.88  0.05  0.01  0.18  2.48 
 4.01 
 12.99 
MESO  2.63  0.15  0.06  0.13  3.23 
 5.49 
 19.08 
HRMY  1.42  0.27  0.13  0.37  1.61 
 3.38 
 10.69 
OCUL  2.92 (0.36) 0.00 (19.12) 0.00 
 6.04 
 36.20 

Vericel Corp Competitive Analysis

The better you understand Vericel Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vericel Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vericel Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
VCEL QURE GPCR EWTX VRDN AUPH NUVB MNKD MESO HRMY
 2.67 
 36.94 
Vericel
 12.55 
 27.80 
Uniqure
 6.75 
 83.78 
Structure
 2.63 
 29.65 
Edgewise
 3.92 
 31.90 
Viridian
 0.07 
 15.21 
Aurinia
 7.44 
 5.63 
Nuvation
 3.33 
 6.21 
MannKind
 0.87 
 17.34 
Mesoblast
 0.95 
 37.48 
Harmony
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Vericel Corp Competition Performance Charts

Five steps to successful analysis of Vericel Corp Competition

Vericel Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vericel Corp Ord in relation to its competition. Vericel Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Vericel Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vericel Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vericel Corp Ord, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Vericel Corp position

In addition to having Vericel Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Discretionary ETFs Thematic Idea Now

Consumer Discretionary ETFs
Consumer Discretionary ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out Vericel Corp Correlation with its peers.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.